In today’s recent session, 313.51 million shares of the HCW Biologics Inc (NASDAQ:HCWB) have been traded, and its beta is 0.77. Most recently the company’s share price was $1.30, and it changed around $1.01 or 341.28% from the last close, which brings the market valuation of the company to $46.87M. HCWB at last check was trading at a discount to its 52-week high of $1.93, offering almost -48.46% off that amount. The share price’s 52-week low was $0.28, which indicates that the recent value has risen by an impressive 78.46% since then. We note from HCW Biologics Inc’s average daily trading volume that its 10-day average is 0.17 million shares, with the 3-month average coming to 48.63K.
HCW Biologics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended HCWB as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. HCW Biologics Inc is expected to report earnings per share of -0.12 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HCW Biologics Inc (NASDAQ:HCWB) trade information
Instantly HCWB has been showing a green trend so far today with a performance of 341.28% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.4900 on recent trading dayincreased the stock’s daily price by 12.75%. The company’s shares are currently up 6.12% year-to-date, but still up 260.81% over the last five days. On the other hand, HCW Biologics Inc (NASDAQ:HCWB) is 149.95% up in the 30-day period. We can see from the shorts that 8092.0 shares have been sold at a short interest cover period of 0.28 day(s).
HCW Biologics Inc (HCWB) estimates and forecasts
The year-over-year growth rate is expected to be -100.00%, down from the previous year.
1 analysts expect HCW Biologics Inc to make 1.13M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 1.32M and 2.84M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -100.00%. Forecasts for the next quarter put sales growth at -60.34%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -34.57%.
HCWB Dividends
HCW Biologics Inc’s next quarterly earnings report is expected to be released on 2024-Apr-01.
HCW Biologics Inc (NASDAQ:HCWB)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 52.30% of HCW Biologics Inc shares, and 3.13% of them are in the hands of institutional investors. The stock currently has a share float of 6.56%. HCW Biologics Inc stock is held by 18.0 institutions, with AVANTAX PLANNING PARTNERS, INC. being the largest institutional investor. By 2024-06-30, it held 0.751% of the shares, which is about 0.28 million shares worth $0.18 million.
HIGHTOWER ADVISORS, LLC, with 0.4857% or 0.18 million shares worth $0.12 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
